Northern Trust’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $491K | Sell |
280,650
-2,497
| -0.9% | -$4.54K | ﹤0.01% | 3623 |
|
|
2025
Q4 | $665K | Buy |
+283,147
| New | +$544K | ﹤0.01% | 3550 |
|
|
2022
Q4 | – | Sell |
-31
| Closed | -$2K | – | 4695 |
|
|
2022
Q3 | $2K | Hold |
31
| – | – | ﹤0.01% | 4701 |
|
|
2022
Q2 | $9K | Hold |
31
| – | – | ﹤0.01% | 4703 |
|
|
2022
Q1 | $25K | Hold |
31
| – | – | ﹤0.01% | 4647 |
|
|
2021
Q4 | $30K | Buy |
+31
| New | +$54.2K | ﹤0.01% | 4669 |
|
|
2021
Q2 | – | Sell |
-4
| Closed | -$31K | – | 4622 |
|
|
2021
Q1 | $31K | Hold |
4
| – | – | ﹤0.01% | 4416 |
|
|
2020
Q4 | $16K | Buy |
+4
| New | +$12K | ﹤0.01% | 4330 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | -$9K | – | 4312 |
|
|
2020
Q2 | $9K | Buy |
+3
| New | +$10.8K | ﹤0.01% | 4222 |
|
|
2019
Q3 | – | Hold |
0
| – | -$7K | – | 4280 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4225 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4160 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4214 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4194 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4183 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4097 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4109 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4128 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3938 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3940 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4031 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4020 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4047 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3903 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3859 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$1.84M | – | 3800 |
|
|
2015
Q2 | $1.34M | Hold |
1
| – | – | ﹤0.01% | 3234 |
|
|
2015
Q1 | $1.5M | Hold |
1
| – | – | ﹤0.01% | 3261 |
|
|
2014
Q4 | $2.09M | Hold |
1
| – | – | ﹤0.01% | 3075 |
|
|
2014
Q3 | $2.61M | Buy |
+1
| New | +$4.03M | ﹤0.01% | 2926 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3401 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3516 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3580 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3595 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3731 |
|
Other funds holding PALI
BGI
OCA
PA
CC
RCM
EP
Northern Trust's PALI Position: Q1 2026 in Review
Northern Trust reduced its Palisade Bio (PALI) stake by 0.88% in Q1 2026, selling an estimated $4.54K and leaving 280,650 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #3623.
Northern Trust first reported a position in PALI in Q3 2014 and has held it in 13 quarters since. The position peaked at $2.61M in Q3 2014. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.
- Northern Trust held 280,650 shares of Palisade Bio worth $491K as of Q1 2026.
- Northern Trust sold 2,497 Palisade Bio shares in Q1 2026, an estimated $4.54K.
- Palisade Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3623 holding.
- Northern Trust first reported a position in Palisade Bio in Q3 2014 and has held it in 13 quarters since.
- Northern Trust's Palisade Bio position peaked at $2.61M in Q3 2014.
- 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.